BSL_EP028
Asset
Plant extract formulation intended to improve joint mobility and physical performance
- Stage
- Phase 1
- Modality
- Supplement
- Target
- Not known
- 1
- Indication
- 1
- Trial
- 1
- Developer
Indications
1Joint diseases
Phase 1, Completed, NCT04029792, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Owner and partners1
- Trials1
Every asset’s record: target, stage, trials and the evidence behind it.
Updated 7 Oct 2026, 1 source